The Patent Finder

SureGene LLC

Also on record
Records under this name other than patents SureGene LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to SureGene LLC

PatentTitleStatus Expires Confidence
US 7,790,396Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,586,308Genetic markers of mental illness
Lapsed on the fee record
Ended Nov 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 19, 2025From the USPTO record
US 9,738,934Genetic markers of mental illness
Formerly held
Lapsed on the fee record
Ended Aug 22, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2025From the USPTO record
US 8,460,868Genetic markers for schizophrenia and bipolar disorder
Lapsed on the fee record
Ended Jun 11, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 11, 2025From the USPTO record
US 7,985,551Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
Formerly held
Lapsed on the fee record
Ended Jul 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 26, 2023From the USPTO record
US 7,972,793Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
Formerly held
Lapsed on the fee record
Ended Jul 5, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 5, 2023From the USPTO record
US 7,951,542Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
Formerly held
Lapsed on the fee record
Ended May 31, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 31, 2023From the USPTO record
US 7,951,543Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
Formerly held
Lapsed on the fee record
Ended May 31, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 31, 2023From the USPTO record
US 9,040,241Genetic markers of mental illness
Lapsed on the fee record
Ended May 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 26, 2023From the USPTO record
US 7,932,042Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature
Formerly held
Lapsed on the fee record
Ended Apr 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded Apr 26, 2023From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited